Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome

Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome

Bibliographic Details
Main Authors:	Mary C. Boulanger, Marisa G. Tieger, Dean Eliott, Andrew J. Yee
Format:	Article
Language:	English
Published:	Wiley 2024-04-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.883

Similar Items

Raynaud’s phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report
by: Fabio Torres-Saavedra, et al.
Published: (2022-05-01)

Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report
by: Shiran Paranavitane, et al.
Published: (2019-12-01)

First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)
by: Omur Gokmen Sevindik, et al.
Published: (2022-07-01)

Adenopathy and extensive skin patch overlying plasmacytoma syndrome—the clue to early diagnosis of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes: A case series and literature review
by: Elizabeth Guevara Sanchez, et al.
Published: (2022-04-01)

Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome
by: Qin Wang, et al.
Published: (2019-07-01)

Successful stabilisation of nephropathy in a patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, skin changes) syndrome on treatment with mycophenolate and steroids: a case report
by: Gray Martin C, et al.
Published: (2010-02-01)

POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin lesions) syndrome: a South America's report POEMS (polineuropatia, organomegalia, endocrinopatia, proteína M, alterações de pele): relato sul-americano
by: Ana Claudia Celestino Leite, et al.
Published: (2007-06-01)

Unraveling the Neurological Complexity of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome: A Report of a Challenging Case of a Young Woman and Cutting-Edge Advancements in the Field
by: Gioconda Furciniti, et al.
Published: (2023-11-01)

Poems syndrome: The rare endocrinopathy
by: Miletić Marija, et al.
Published: (2024-01-01)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
by: Jacob T. Cox, et al.
Published: (2021-03-01)

Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report
by: Ryutaro Taenaka, et al.
Published: (2022-08-01)

Paraneoplastic endocrinopathy in Castleman disease and POEMS syndrome
by: V. I. Odin, et al.
Published: (2020-10-01)

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
by: Heier, J, et al.
Published: (2012)

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-Related Macular Degeneration
by: Heier, J, et al.
Published: (2012)

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
by: Daniele Veritti, et al.
Published: (2023-05-01)

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by: Johannes P. M. van de Mortel, et al.
Published: (2022-10-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
by: J. Bladé
Published: (2023-05-01)

Monoclonal Gammopathy of Thrombotic Significance
by: Vasiliki Gkalea, et al.
Published: (2023-01-01)

Monoclonal gammopathy of “ocular” significance
by: Sezen Karakus, et al.
Published: (2019-09-01)

Cutaneous manifestations of monoclonal gammopathy
by: Jean-Sebastien Claveau, et al.
Published: (2022-04-01)

Monoclonal gammopathies of renal significance
by: Fernando Caravaca-Fontán, et al.
Published: (2017-09-01)

Urinary Neopterin in Monoclonal Gammopathies
by: Denz H., et al.
Published: (1990-05-01)

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
by: Tomoaki Tatsumi, et al.
Published: (2022-06-01)

Acute Kidney Injury in Monoclonal Gammopathies
by: Paolo Menè, et al.
Published: (2021-08-01)

Necrobiotic Xanthogranuloma as Sign of Monoclonal Gammopathy
by: Claudio Conforti, et al.
Published: (2022-10-01)

Oligosecretory monoclonal gammopathy with renal involvement
by: L V Kozlovskaya, et al.
Published: (2016-12-01)

Monoclonal gammopathy associated with visceral leishmaniasis
by: Vishal Sharma, MD, et al.
Published: (2010-05-01)

Monoclonal gammopathy associated with visceral leishmaniasis
by: Vishal Sharma, et al.

Intravitreal aflibercept for ruptured retinal arterial macroaneurysm
by: Zafer Oztas, et al.
Published: (2017-03-01)

POEMS Syndrome with Biclonal Gammopathy: A Rare Association
by: DIBYENDU DE, et al.
Published: (2017-07-01)

Assessment of mouse VEGF neutralization by ranibizumab and aflibercept.
by: Yusuke Ichiyama, et al.
Published: (2022-01-01)

Prevalence of MGCS Among Patients With Monoclonal Gammopathies
by: Foteini Theodorakakou, et al.
Published: (2023-06-01)

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
by: David F. Moreno, et al.
Published: (2021-10-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Monoclonal Gammopathy of Undetermined Significance and Neutrophilic Dermatosis
by: Buthaina Al-Musalhi, et al.
Published: (2016-09-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

“Acute” monoclonal gammopathy in severe COVID-19
by: Natale Vazzana, et al.
Published: (2020-07-01)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
by: Louis-Pierre Girard, et al.
Published: (2022-06-01)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
by: Nabeel Aslam, MD, et al.
Published: (2021-08-01)